Canopy Growth Corp Stock Today
| CGC Stock | USD 3.90 0.04 1.02% |
Performance0 of 100
| Odds Of DistressOver 82
|
Canopy Growth is trading at 3.90 as of the 28th of November 2024, a 1.02% down since the beginning of the trading day. The stock's open price was 3.94. Canopy Growth has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Canopy Growth Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of December 2022 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 4th of April 2014 | Category Healthcare | Classification Health Care |
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada. The company has 105.36 M outstanding shares of which 8.22 M shares are currently shorted by investors with about 1.36 days to cover. More on Canopy Growth Corp
Moving together with Canopy Stock
Moving against Canopy Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Canopy Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO | David Klein | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Cannabis (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Names | [Aris Gold Corporation, CHINA GREEN (HLDGS), CHINA GREEN (HLDGS), CHINA GREEN (CGC.SG), CHINA GREEN (HLDGS) - Frankfurt Stock Exchang, Costa Group Holdings Ltd] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, Australia All Ordinaries, ASX Small Ordinaries, SPASX 200, SPASX 300, SPASX 200 Accumulated, Cannabis, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsCanopy Growth can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Canopy Growth's financial leverage. It provides some insight into what part of Canopy Growth's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Canopy Growth Corp (CGC) is traded on NASDAQ Exchange in USA. It is located in 1 Hershey Drive, Smiths Falls, ON, Canada, K7A 0A8 and employs 1,029 people. Canopy Growth is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a total capitalization of 521.02 M. Canopy Growth Corp runs under Pharmaceuticals sector within Health Care industry. The entity has 105.36 M outstanding shares of which 8.22 M shares are currently shorted by investors with about 1.36 days to cover.
Canopy Growth Corp has about 1.23 B in cash with (281.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.94.
Check Canopy Growth Probability Of Bankruptcy
Ownership AllocationCanopy Growth holds a total of 105.36 Million outstanding shares. Almost 91.05 percent of Canopy Growth outstanding shares are held by general public with 0.17 (percent) owned by insiders and only 8.78 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Canopy Ownership Details
Canopy Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Engineers Gate Manager Lp | 2024-09-30 | 121.4 K | |
| Millennium Management Llc | 2024-06-30 | 121.4 K | |
| Bank Of Montreal | 2024-06-30 | 115.3 K | |
| Bmo Capital Markets Corp. | 2024-06-30 | 115.3 K | |
| Baader Bank Inc | 2024-09-30 | 114.9 K | |
| Squarepoint Ops Llc | 2024-06-30 | 91.2 K | |
| Advisorshares Investments, Llc | 2024-09-30 | 90.9 K | |
| Imc-chicago, Llc | 2024-09-30 | 78.9 K | |
| Td Asset Management Inc | 2024-09-30 | 75.4 K | |
| Tidal Investments Llc. | 2024-09-30 | 2 M | |
| Morgan Stanley - Brokerage Accounts | 2024-06-30 | 1 M |
Canopy Growth Historical Income Statement
Canopy Stock Against Markets
Canopy Growth Corporate Management
| Mark Ware | Chief Medical Officer | Profile | |
| Terry Yanofsky | Director | Profile | |
| FCPA FCA | Strategic Advisor | Profile | |
| Robert Hanson | Independent Director | Profile | |
| Christelle LLB | Chief Secretary | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Canopy Growth Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Canopy Growth. If investors know Canopy will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Canopy Growth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.10) | Revenue Per Share 3.315 | Quarterly Revenue Growth (0.1) | Return On Assets (0.04) | Return On Equity (0.93) |
The market value of Canopy Growth Corp is measured differently than its book value, which is the value of Canopy that is recorded on the company's balance sheet. Investors also form their own opinion of Canopy Growth's value that differs from its market value or its book value, called intrinsic value, which is Canopy Growth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Canopy Growth's market value can be influenced by many factors that don't directly affect Canopy Growth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Canopy Growth's value and its price as these two are different measures arrived at by different means. Investors typically determine if Canopy Growth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Canopy Growth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.